Performance of a novel test for IgM and IgG antibodies in subjects with culture-documented genital herpes simplex virus-1 or -2 infection

Clinical Microbiology and Infection

Volumn 12, Issue 5, 2006, Pages 463-469

  Morrow, Rhoda ^a,b   Friedrich, D ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

Diagnosis; Genital herpes; Herpes simplex virus; IgG type specific serology; IgM tests; Seroconversion

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENITAL HERPES; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; SEROLOGY; VIRUS DETECTION;

HERPES; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; SIMPLEXVIRUS;

EID: 33645646352     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2006.01370.x     Document Type: Article

References (24)

1. Wald A, Ashley-Morrow R. Serological testing for herpes simplex virus (HSV)-1 and HSV-2 infection. Clin Infect Dis 2002; 35 (suppl 2): S173-S182.
2. Ashley R, Cent A, Maggs V, Nahmias A, Corey L. Inability of enzyme immunoassays to discriminate between infections with herpes simplex virus types 1 or 2. Ann Intern Med 1991; 115: 520-526.
3. Martins T, Woolstenhulme R, Jaskowski T, Hill H, Litwin C. Comparison of four enzyme immunoassays with a western blot assay for the determination of type-specific antibodies to herpes simplex virus. Am J Clin Pathol 2001; 115: 272-277.
4. Morrow RA, Friedrich D. Inaccuracy of certain commercial enzyme immunoassays in diagnosing genital infections with herpes simplex virus type 1 or 2. Am J Clin Pathol 2003; 120: 839-844.
5. Klutts JS, Liao RS, Dunne Jr WM, Gronowski AM. Evaluation of a multiplexed bead assay for assessment of Epstein-Barr virus (EBV) immunologic status. J Clin Microbiol 2004; 42: 4996-5000.
6. Kaul R, Chen P, Binder SR. Detection of immunoglobulin M antibodies specific for Toxoplasma gondii with increased selectivity for recently acquired infections. J Clin Microbiol 2004; 42: 5705-5709.
7. Ashley RL, Militoni J, Lee F, Nahmias A, Corey L. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol 1988; 26: 662-667.
8. Corey L, Handsfield HH. Genital herpes and public health: Addressing a global problem. JAMA 2000; 283: 791-794.
9. Fleming D, McQuillan G, Johnson R et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997; 337: 1105-1111.
10. Johnson R, Nahmias A, Magder L, Lee F, Brooks C, Snowden M. A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med 1989; 321: 7-12.
11. Serwadda D, Gray RH, Sewankambo NK et al. Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2; a nested case-control study in Rakai, Uganda. J Infect Dis 2003; 188: 1492-1497.
12. Wald A, Link K. Risk of human immunodeficiency virus in herpes simplex virus type 2-seropositive persons: A meta-analysis. J Infect Dis 2002; 185: 45-52.
13. Corey L, Wald A, Celum C, Quinn TC. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: A review of two overlapping epidemics. J AIDS 2004; 35: 435-445.
14. Corey L, Wald A, Patel R et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Eng J Med 2004; 350: 11-20.
15. Wald A, Langenberg AGM, Link K et al. Effect of condoms on reducing the transmission of herpes simplex virus type-2 from men to women. JAMA 2001; 285: 3100-3106.
16. Fairley I, Monteiro E. Patient attitudes to type specific serological tests in the diagnosis of genital herpes. Genitourin Med 1998; 73: 259-262.
17. Brugha R, Brown D, Meheus A, Renton A. Should we be screening for asymptomatic HSV infection? Sex Transm Infect 1999; 75: 142-144.
18. Edmiston N, O'Sullivan M, Charters D, Chuah J, Pallis L. Study of knowledge of genital herpes infection and attitudes to testing for genital herpes among antenatal clinic attendees. Aust NZ J Obstet Gynaecol 2003; 43: 351-353.
19. Ashley RL. Type-specific antibodies to HSV-1 and -2: Review of methodology. Herpes 1998; 5: 33-38.
20. Ashley RL. Performance and use of HSV type specific serology test kits. Herpes 2002; 9: 38-45.
21. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR 2002; 51: 1-80.
22. Ashley-Morrow R, Krantz E, Wald A. Time course of seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2. Sex Transm Dis 2003; 30: 310-314.
23. Ho DWT, Field PR, Sjogren-Jansson E, Jeansson S, Cunningham AL. Indirect ELISA for the detection of HSV-2 specific IgG and IgM antibodies with glycoprotein G (gG-2). J Virol Methods 1992; 36: 249-264.
24. Leach CT, Ashley R, Baillargeon J, Jenson HB. Performance of two commercial glycoprotein G-based enzyme immunoassays for detecting antibodies to herpes simplex viruses 1 and 2 in children and young adolescents. Clin Diagn Lab Immunol 2002; 9: 1124-1125.